Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver DiseaseArun J. Sanyal, James Tonascia, Jeanne M. Clark et al.|New England Journal of Medicine|2021Cited by 1.1k
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver DiseaseMohammad Shadab Siddiqui, Arun J. Sanyal, Raj Vuppalanchi et al.|Clinical Gastroenterology and Hepatology|2018Cited by 593
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose TissueRebecca C. Schugar, J. Mark Brown, Diana M. Shih et al.|Cell Reports|2017Cited by 290
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050Phuc Le, Michael B. Rothberg, Moosa Tatar et al.|JAMA Network Open|2025Cited by 177